{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:49:49Z","timestamp":1791323389014,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":501,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejca.2012.06.018","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T03:45:14Z","timestamp":1344051914000},"page":"3429-3438","source":"Crossref","is-referenced-by-count":42,"title":["The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Alexander B.","family":"Mohseny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Kuijjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendy","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"de Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pancras C.W.","family":"Hogendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Cleton-Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2012.06.018_b0005","series-title":"World Health Organization classification of tumours; Pathology and genetics of tumours of soft tissue and bone","first-page":"259","article-title":"Osteogenic tumours","author":"Fletcher","year":"2002"},{"key":"10.1016\/j.ejca.2012.06.018_b0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djk015","article-title":"Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup","volume":"99","author":"Lewis","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2012.06.018_b0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/CCO.0b013e32833aaac1","article-title":"Trabectedin therapy for sarcomas","volume":"22","author":"Casali","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejca.2012.06.018_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.2603","article-title":"Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2","volume":"219","author":"Mohseny","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/stem.596","article-title":"Concise review: mesenchymal tumors: when stem cells go mad","volume":"29","author":"Mohseny","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.ejca.2012.06.018_b0030","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s11999-008-0335-z","article-title":"Osteosarcoma development and stem cell differentiation","volume":"466","author":"Tang","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2635","article-title":"Wnts, bone and cancer","volume":"220","author":"Thomas","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/path.2628","article-title":"Inactive Wnt\/beta-catenin pathway in conventional high-grade osteosarcoma","volume":"220","author":"Cai","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cytogfr.2009.10.010","article-title":"Smad signaling in skeletal development and regeneration","volume":"20","author":"Song","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ejca.2012.06.018_b0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.2785","article-title":"The dynamic roles of TGF-beta in cancer","volume":"223","author":"Meulmeester","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0055","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massague","year":"2005","journal-title":"Gene Dev"},{"key":"10.1016\/j.ejca.2012.06.018_b0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1359\/jbmr.2000.15.6.1045","article-title":"Expression of Indian Hedgehog, PTHrP and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth","volume":"15","author":"Van der Eerden","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0065","series-title":"Nature encyclopedia of the human genome","first-page":"306","article-title":"Skeletogenesis: genetics","author":"Hogendoorn","year":"2003"},{"key":"10.1016\/j.ejca.2012.06.018_b0205","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage-activating agents","volume":"17","author":"Buddingh\u2019","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejca.2012.06.018_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/gcc.20717","article-title":"Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort","volume":"49","author":"Ottaviano","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ejca.2012.06.018_b0085","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.M111023200","article-title":"Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter","volume":"277","author":"Korchynskyi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2012.06.018_b0090","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2012.06.018_b0095","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nature00989","article-title":"Patched acts catalytically to suppress the activity of Smoothened","volume":"418","author":"Taipale","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2012.06.018_b0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.ejca.2012.06.018_b0105","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.bjc.6605405","article-title":"Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways","volume":"101","author":"Cleton-Jansen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2012.06.018_b0210","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/labinvest.2011.72","article-title":"Functional characterization of osteosarcoma cell lines provides representative models to study the human disease","volume":"91","author":"Mohseny","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2012.06.018_b0115","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/1097-0142(19851001)56:7<1682::AID-CNCR2820560735>3.0.CO;2-8","article-title":"Clinical significance of bone morphogenetic activity in osteosarcoma. A study of 20 cases","volume":"56","author":"Yoshikawa","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.06.018_b0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/1097-0142(19880201)61:3<569::AID-CNCR2820610324>3.0.CO;2-Z","article-title":"Prognostic significance of bone morphogenetic activity in osteosarcoma tissue","volume":"61","author":"Yoshikawa","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2012.06.018_b0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00003086-199908000-00023","article-title":"Expression of bone morphogenetic proteins and receptors in sarcomas","volume":"283","author":"Guo","year":"1999","journal-title":"Clin Orthop"},{"key":"10.1016\/j.ejca.2012.06.018_b0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jcp.55.5.381","article-title":"The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter","volume":"55","author":"Sulzbacher","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0135","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","article-title":"Novel regulators of bone formation: molecular clones and activities","volume":"242","author":"Wozney","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ejca.2012.06.018_b0140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00776-004-0764-9","article-title":"Bone morphogenetic proteins in bone tumors","volume":"9","author":"Yoshikawa","year":"2004","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.ejca.2012.06.018_b0145","first-page":"2219","article-title":"Expression of bone morphogenetic proteins in giant cell tumor of bone","volume":"29","author":"Kudo","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","article-title":"Transforming growth factor-beta1 to the bone","volume":"26","author":"Janssens","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejca.2012.06.018_b0155","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","article-title":"TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation","volume":"20","author":"Alliston","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2012.06.018_b0160","first-page":"7791","article-title":"SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells","volume":"63","author":"Matsuyama","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z","article-title":"Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas","volume":"185","author":"Franchi","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.184.133","article-title":"Relation between histological intensity of transforming growth factor-beta isoforms in human osteosarcoma and the rate of lung metastasis","volume":"184","author":"Yang","year":"1998","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ejca.2012.06.018_b0175","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/0008-5472.CAN-10-2698","article-title":"Induction of monocyte chemoattractant protein-1 and interleukin-10 by TGFbeta1 in melanoma enhances tumor infiltration and immunosuppression","volume":"71","author":"Diaz-Valdes","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00262-010-0965-3","article-title":"Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells","volume":"60","author":"Buddingh\u2019","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ejca.2012.06.018_b0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/path.2008","article-title":"Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog (IHH) signalling","volume":"209","author":"Hameetman","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2012.06.018_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-9-5","article-title":"Smoothened as a new therapeutic target for human osteosarcoma","volume":"9","author":"Hirotsu","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejca.2012.06.018_b0195","first-page":"5535","article-title":"Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas","volume":"53","author":"Khatib","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2012.06.018_b0200","first-page":"5407","article-title":"Amplification of the gli gene in childhood sarcomas","volume":"49","author":"Roberts","year":"1989","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912005217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912005217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T18:02:28Z","timestamp":1542823348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912005217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0959804912005217"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.06.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}